Sebastijan Hobor

Sebastijan Hobor

Francis Crick Institute - London / United Kingdom
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4472324
person_outline Sebastijan Hobor's MOST POPULAR ARTICLES
1-) Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerS Misale, R Yaeger, S Hobor, E Scala, M Janakiraman, D Liska, E Valtorta, ...Nature 486 (7404), 532-536, 201218302012
2-) Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsG Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ...Nature medicine 21 (7), 795-801, 20159492015
3-) Reversible and adaptive resistance to BRAF (V600E) inhibition in melanomaC Sun, L Wang, S Huang, GJJE Heynen, A Prahallad, C Robert, ...Nature 508 (7494), 118-122, 20147792014
4-) Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal CancerA Bardelli, S Corso, A Bertotti, S Hobor, E Valtorta, G Siravegna, ...Cancer discovery 3 (6), 658-673, 20137172013
5-) Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renalS Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ...Cell 173 (3), 595-610. e11, 20186062018